Clinical Trials Logo

Clinical Trial Summary

The main objective of the study is to describe the antimicrobial resistance profile of E. coli isolated in patients from the community - defined as those with cultures collected within 48 hours of hospital admission - and admitted to the intensive care unit.


Clinical Trial Description

Background: The growing antimicrobial resistance in bacterial pathogens represents a severe public health problem. Isolation of Escherichia coli ESBL has been identified more frequently over the years due to the worldwide dissemination of strains with this phenotypic profile. The ICU has a fully functioning Antimicrobial Stewardship team, with data managed daily. Thus, the investigators identified increasing E. coli ESBL isolates resistant to standard empiric antimicrobial therapy in community-based severe infections. Purpose: The choice of empirical antimicrobial therapy is an increasingly present challenge in clinical practice, often determining the outcome of critically ill patients. As this is a highly relevant topic in managing this patient profile, antimicrobial stewardship protocols are essential in health services, enabling continuous community monitoring of emerging resistance profiles. The justification for this study is based on the possibility of adding knowledge on the topic, aiming to add to the global theoretical collection and alert about the locoregional occurrence of changes in the bacterial resistance profile. Objectives: The main objective of the study is to describe the antimicrobial resistance profile of E. coli isolated in patients from the community - defined as those with cultures collected within 48 hours of hospital admission - and admitted to the ICU. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06305455
Study type Observational
Source Hospital Sao Domingos
Contact RODRIGO AZEVEDO, MD, PhD
Phone +55 98 991920321
Email rpdeazevedo@gmail.com
Status Not yet recruiting
Phase
Start date April 2024
Completion date October 2024

See also
  Status Clinical Trial Phase
Completed NCT04182230 - UROGEN WELL D-ONE : Evaluation of a Novel Diagnostic for Sexually Transmitted Bacterial Infections
Recruiting NCT02814877 - Efficacy and Cost-effectiveness of Hospital Antimicrobial Stewardship Programs N/A
Completed NCT03388944 - PCT Guided Stopping of Antibiotic Therapy in Children With Sepsis N/A
Completed NCT05734391 - Surveillance of Healthcare-associated Infections & Antimicrobial Resistance
Completed NCT03794479 - Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
Recruiting NCT05942157 - Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections N/A
Recruiting NCT05296837 - Ocular Rosacea Biome Study Phase 4
Completed NCT05451836 - N-of-1 Trials of Interventions to Improve Decision-making for Antibiotic Use N/A
Not yet recruiting NCT05960084 - Impact of Reducing Colistin Use on Colistin Resistance in Humans and Poultry in Indonesia
Not yet recruiting NCT06436690 - Optimizing Antibiotics Prescription N/A
Completed NCT05445414 - A Mobile App Serious Game to Increase Awareness of Antibiotic Use in the Community N/A
Not yet recruiting NCT05089760 - Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in China
Recruiting NCT04388293 - Using Antibiotics Wisely - An Antimicrobial Stewardship Program
Completed NCT05285657 - Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases. N/A
Completed NCT03479710 - Fecal Microbiota Transplantation for CRE/VRE Phase 2
Recruiting NCT06358872 - Azithromycin for Child Survival in Niger II Phase 4
Not yet recruiting NCT06356285 - Testing New Ways to Name Antimicrobial Resistance N/A